Square Pharma
Production at API Industrial Park to begin next month
Production of active pharmaceutical ingredients (APIs) at the API Industrial Park in Gazaria of Munshiganj will begin next month, with ACME Laboratories set to commission its manufacturing unit despite the lack of gas supply.
Square Pharmas logged Tk 1,898cr profit in FY23
Square Pharmaceuticals registered a 4.53 percent year-on-year growth in profit to Tk 1,898 crore
Square Pharmaceuticals announces Tk 400 crore expansion plan
Square Pharmaceuticals Ltd, the country’s biggest drug maker, has announced today its plan to invest Tk 400 crore for expansion. The funds would be used for BMRE (Balancing, Modernisation, Rehabilitation and Expansion), and the purchase of capital machinery and land for the future expansion of its business.
Square pharma signs contract manufacturing deal with Euro Pharma
Square Pharmaceuticals PLC has struck a contract manufacturing agreement with Euro Pharma Ltd.
Square Pharma’s profit growth slows
Square Pharma today said its profit growth slowed down in the first quarter of the financial year ending on September 30 as its operating expenses soared.
Production at API Industrial Park to begin next month
Production of active pharmaceutical ingredients (APIs) at the API Industrial Park in Gazaria of Munshiganj will begin next month, with ACME Laboratories set to commission its manufacturing unit despite the lack of gas supply.
Square Pharmas logged Tk 1,898cr profit in FY23
Square Pharmaceuticals registered a 4.53 percent year-on-year growth in profit to Tk 1,898 crore
Square Pharmaceuticals announces Tk 400 crore expansion plan
Square Pharmaceuticals Ltd, the country’s biggest drug maker, has announced today its plan to invest Tk 400 crore for expansion. The funds would be used for BMRE (Balancing, Modernisation, Rehabilitation and Expansion), and the purchase of capital machinery and land for the future expansion of its business.
Square pharma signs contract manufacturing deal with Euro Pharma
Square Pharmaceuticals PLC has struck a contract manufacturing agreement with Euro Pharma Ltd.
Square Pharma’s profit growth slows
Square Pharma today said its profit growth slowed down in the first quarter of the financial year ending on September 30 as its operating expenses soared.
